Real‐world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK ‐positive NSCLCYasushi Goto,Takehito Shukuya,Ai Murata,Hironori Kikkawa,Birol Emir,Robin Wiltshire,Satoru MiuraCancer Science(2023)引用 0|浏览16暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要